Aprea Therapeutics, Inc. of DOYLESTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-29. The offering totals $5.8M, of which $3.1M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Jean-Pierre P Bizzari | Director | Doylestown, PA |
| Marc P Duey | Director | Doylestown, PA |
| Oren Gilad | Director | Doylestown, PA |
| Michael P Grissinger | Director | Doylestown, PA |
| Gabriela P Gruia | Director | Doylestown, PA |
| John B Henneman | Director | Doylestown, PA |
| Rifat B Pamukcu | Director | Doylestown, PA |
| Richard P Peters | Director | Doylestown, PA |
| Bernd B Seizinger | Director | Doylestown, PA |
| Oren Gilad | Executive Officer | Doylestown, PA |
| John P Hamill | Executive Officer | Doylestown, PA |